(Q37668360)

21 August 2017

1 reference

title

Polyalkylcyanoacrylate nanoparticles for delivery of drugs across the blood-brain barrier (English)

1 reference

21 August 2017

0 references

1 reference

2

Patrick Couvreur

0 references

Karine Andrieux

object named as

Karine Andrieux

series ordinal

1

0 references

publication date

1 September 2009

1 reference

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

21 August 2017

published in

1 reference

21 August 2017

volume

1

1 reference

21 August 2017

issue

5

1 reference

21 August 2017

page(s)

463-474

1 reference

Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain?

21 August 2017

cites work

1 reference

Recent advances in the brain targeting of neuropharmaceuticals by chemical delivery systems

21 January 2018

1 reference

Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting

21 January 2018

1 reference

Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats

21 January 2018

1 reference

Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells.

21 January 2018

1 reference

Pegylated nanoparticles from a novel methoxypolyethylene glycol cyanoacrylate-hexadecyl cyanoacrylate amphiphilic copolymer

21 January 2018

1 reference

Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting

21 January 2018

1 reference

Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues.

21 January 2018

1 reference

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

21 January 2018

1 reference

Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26.

21 January 2018

1 reference

Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications

21 January 2018

1 reference

Nanoparticles in cancer therapy and diagnosis

21 January 2018

1 reference

Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles.

21 January 2018

1 reference

Molecular weights of poly(butyl cyanoacrylate) nanoparticles determined by mass spectrometry and size exclusion chromatography

21 January 2018

1 reference

Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly(butyl cyanoacrylate) nanoparticles

21 January 2018

1 reference

Nanoparticles--a historical perspective

21 January 2018

1 reference

Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles

21 January 2018

1 reference

Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants

21 January 2018

1 reference

Efficacy of oral dalargin-loaded nanoparticle delivery across the blood-brain barrier

21 January 2018

1 reference

Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles.

21 January 2018

1 reference

Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study

21 January 2018

1 reference

Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain

21 January 2018

1 reference

Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model

21 January 2018

1 reference

Double-coated poly (butylcynanoacrylate) nanoparticulate delivery systems for brain targeting of dalargin via oral administration

21 January 2018

1 reference

Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns.

21 January 2018

1 reference

Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles

21 January 2018

1 reference

Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier

21 January 2018

1 reference

Interaction of poly(butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo and in vitro

21 January 2018

1 reference

Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat.

21 January 2018

1 reference

PEGylated polycyanoacrylate nanoparticles as vector for drug delivery in prion diseases

21 January 2018

1 reference

Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery

21 January 2018

1 reference

Translocation of poly(ethylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptor-mediated endocytosis

21 January 2018

1 reference

Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2-DE, CE and Protein Lab-on-chip system

21 January 2018

1 reference

A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles

21 January 2018

1 reference

Transporting therapeutics across the blood-brain barrier

21 January 2018

1 reference

A methodology to study intracellular distribution of nanoparticles in brain endothelial cells

21 January 2018

1 reference

Low-density lipoprotein receptor-mediated endocytosis of PEGylated nanoparticles in rat brain endothelial cells

21 January 2018

1 reference

The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres.

21 January 2018

1 reference

Drug delivery to damaged brain

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/WNAN.5

1 reference

21 August 2017

1 reference